Spliceosome Mutations in Myeloid Malignancies
Daniel R. Larson (Laboratory of Receptor Biology and Gene expression, NCI, Bethesda, US)
12
June 2024
![](/sites/default/files/styles/930xauto/public/media/2024-05/larson_daniel_web3.jpg?h=3f3c87ef&itok=KaBknLOM)
Pratical info
The differentiation of hematopoietic stem cells into committed lineages in the blood is the result of concerted regulation between transcription, splicing and translation, and a goal of the laboratory is to understand the dynamic interplay between these processes in single cells. Overall, gene regulation in this tissue is exceptionally dependent on post-transcriptional mechanisms, as evidenced in myelodysplasia with mutations in RNA splicing factors. The team has discovered a non-canonical role for the splicing factor U2AF1 in mitochondria homeostasis and reported substantial changes in mitochondrial function and metabolism of MDS cells.
Daniel Larson is invited by Michaela Fontenay.